HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

iniparib

a PARP1 inhibitor with antineoplastic activity
Also Known As:
4-iodo-3-nitrobenzamide; BSI 201; BSI-201; BSI201
Networked: 47 relevant articles (8 outcomes, 25 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Charpentier, Eric: 4 articles (09/2019 - 12/2014)
2. Garcia-Ribas, Ignacio: 3 articles (09/2019 - 12/2014)
3. Carlson, Robert W: 3 articles (01/2017 - 12/2014)
4. Ford, James M: 3 articles (01/2017 - 06/2015)
5. Hartman, Anne-Renee: 3 articles (01/2017 - 06/2015)
6. Jensen, Kristin C: 3 articles (01/2017 - 06/2015)
7. Telli, Melinda L: 3 articles (01/2017 - 06/2015)
8. Winer, Eric P: 3 articles (01/2016 - 08/2014)
9. Bonnefoi, Hervé: 2 articles (09/2019 - 11/2015)
10. Blakeley, Jaishri O: 2 articles (01/2019 - 10/2015)

Related Diseases

1. Triple Negative Breast Neoplasms
2. Neoplasms (Cancer)
3. Ovarian Neoplasms (Ovarian Cancer)
4. Pancreatic Neoplasms (Pancreatic Cancer)
5. Breast Neoplasms (Breast Cancer)

Related Drugs and Biologics

1. Poly(ADP-ribose) Polymerase Inhibitors
2. Gemcitabine
3. Carboplatin (JM8)
4. olaparib
5. Platinum
6. Irinotecan (Camptosar)
7. Topoisomerase I Inhibitors
8. Reactive Oxygen Species (Oxygen Radicals)
9. Paclitaxel (Taxol)
10. Cisplatin (Platino)

Related Therapies and Procedures

1. Drug Therapy (Chemotherapy)
2. Therapeutics
3. Neoadjuvant Therapy
4. Stents
5. Radiotherapy